iMethods Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • iMethods's estimated annual revenue is currently $15.1M per year.(i)
  • iMethods's estimated revenue per employee is $145,000

Employee Data

  • iMethods has 104 Employees.(i)
  • iMethods grew their employee count by 21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.5M86-9%N/AN/A
#2
$4.1M3657%N/AN/A
#3
$3.9M340%N/AN/A
#4
$9M72-3%N/AN/A
#5
$9.4M727%N/AN/A
#6
$3.9M3540%N/AN/A
#7
$4.2M360%N/AN/A
#8
$36M22675%N/AN/A
#9
$14.8M1029%N/AN/A
#10
$0.7M9N/AN/AN/A

iMethods is a Healthcare IT Consulting and Staffing firm dedicated to guiding hospitals through the challenges associated with implementing and leveraging their healthcare technology. Our mission is to create meaningful work in every community we serve. We are driven with the purpose of helping you improve patient outcomes by providing quality solutions, building meaningful relationships, and delivering exceptional results.

keywords:Career / Job Search,Healthcare,Healthcare Providers,Human Resources Hr

N/A

Total Funding

104

Number of Employees

$15.1M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

iMethods News

2019-06-26 - Eggplant and iMethods Expand Relationship

iMethods attains Eggplant Endorsed Service Provider status. Boulder, CO, June 26, 2019: Eggplant the intelligent test automation specialist, ...

2018-07-20 - Freedom van conversion answers call for need of onboard ...

“It's one of those issues you don't talk about,” said her husband, Clint Drawdy, president, COO and co-founder of iMethods, a healthcare IT ...

2018-06-21 - Attis Industries acquires clean technology licensing business

... and the rights to many proprietary, patented and patent-pending technologies, including (i) methods for real-time data acquisition, verification ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.3M104478%N/A
#2
$17.7M10428%N/A
#3
$3.5M10521%N/A
#4
$27.1M10513%N/A
#5
$26.6M10517%N/A